NCT05482087 2022-08-01A Study of XZP-3621 in Chinese Patients With ALK Positive NSCLCXuanzhu Biopharmaceutical Co., Ltd.Phase 2 Unknown190 enrolled
NCT04056572 2019-10-30Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With CrizotinibChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2 Unknown135 enrolled